Assessing Genpact (G) Valuation After Recent Share Price Weakness

Genpact

Genpact

G

0.00

Recent performance snapshot for Genpact (G)

Genpact (G) has drawn investor attention after a period where the stock is down about 4% over the past month and roughly 18% over the past 3 months, with year to date returns also lower.

At a last close of US$32.95 and a market cap near US$5.6b, the company sits against a backdrop of annual revenue of US$5.16b and net income of US$569.63m.

While the stock’s 1 day and 7 day share price returns are positive, the longer trend shows momentum has faded, with the 1 year total shareholder return also declining.

If you are reassessing your portfolio after Genpact’s recent weakness, this can be a good moment to broaden your research and check out 20 top founder-led companies

With Genpact’s share price weaker over the past year despite annual revenue of US$5.16b and net income of US$569.63m, it raises the real question for you: is this weakness a potential opportunity, or is the market already pricing in future growth?

Most Popular Narrative: 31% Undervalued

Genpact’s most followed valuation narrative points to a fair value of about $47.73 per share, compared with the recent close at $32.95, which is a sizeable gap for investors to understand.

Accelerated client adoption of Genpact's Advanced Technology Solutions, particularly in data and AI, should drive higher growth and improved margins, as these offerings deliver over twice the revenue per headcount versus legacy services and are expanding at over twice the company's overall rate, pointing toward robust long-term revenue and margin expansion.

Want to see what is behind that optimism on higher margin AI work and premium contracts? The narrative focuses on compounding revenue, firmer margins, and a richer earnings profile over time. The core of the story is how those assumptions stack up against today’s share price and discount rate.

Result: Fair Value of $47.73 (UNDERVALUED)

However, the story can change quickly if legacy outsourcing slows faster than expected, or if clients delay adopting Genpact’s higher value AI driven solutions.

Next Steps

With sentiment mixed across price action and valuation, it helps to move quickly from headlines to hard numbers and judge the story for yourself. To understand what is driving optimism around the stock, review the 4 key rewards.

Looking for more investment ideas?

If Genpact has you thinking more carefully about where your money works hardest, do not stop here. Use screeners to spot what others might miss.

  • Target potential bargains by scanning companies that combine quality fundamentals with attractive valuations through the 46 high quality undervalued stocks.
  • Strengthen your core holdings by focusing on companies with resilient finances using the solid balance sheet and fundamentals stocks screener (46 results).
  • Get ahead of the crowd by searching for lesser known opportunities via the screener containing 22 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.